Join
Live feed
·
PRReleasevia Quantisnow
Denali Therapeutics Inc. logo
Royalty Pharma plc logo

Denali Therapeutics and Royalty Pharma Announce $275 Million Royalty Funding Agreement

ByQuantisnow·Wall Street's wire, on your screen.
DNLI· Denali Therapeutics Inc.RPRX· Royalty Pharma plc
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track DNLI (Denali Therapeutics Inc.), RPRX (Royalty Pharma plc) and more on Quantisnow.